Skip to main content

Advertisement

SpringerLink
Log in

Expression of Mucoproteins in Gallbladder Cancer

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

This study was designed to evaluate the correlation of expression profiles of MUC2, MUC4, and MUC5AC to the clinico-pathological parameters in gallbladder cancer. We recruited biopsies of a total of 60 subjects including 50 primary tumor biopsies from histopathologically proven gallbladder cancer and 10 cases of chronic cholecystitis as control. We have investigated the expression levels of MUC2, MUC4, and MUC5AC by semi-quantitative RT-PCR and immune-histochemistry in gallbladder cancer biopsies, and chronic cholecystitis as a control. Clinical correlation of the differential expression of MUC2, MUC4, and MUC5AC was determined using appropriate statistical methods. Our results demonstrated that MUC2 was significantly (p = 0.004) upregulated in 16%, MUC4 was significantly (p = 0.0004) upregulated in 24%, and MUC5AC was significantly (p = 0.003) upregulated in 32% samples at transcript levels in primary gallbladder cancer biopsies in comparison to the control. Similar to RT-PCR data, MUC2 was significantly (p = 0.001) upregulated in 30%, MUC4 was significantly (p = 0.047) upregulated in 48%, and MUC5AC was significantly (p = 0.002) upregulated in 52% samples at proteome levels in primary gallbladder cancer biopsies in comparison to the control. In conclusion, the MUC2, MUC4, and MUC5AC expression were found to be significantly upregulated in gallbladder cancer group than control. The overexpression of MUC2, MUC4, and MUC5AC suggested their association with gallbladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rakić M, Patrlj L, Kopljar M, Kliček R, Kolovrat M, Loncar B, Busic Z (2014) Gallbladder cancer Hepatobiliary Surg Nutr 3:221–226

    PubMed  Google Scholar 

  2. Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. Oncologist 15:168–181

    Article  CAS  Google Scholar 

  3. Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109

    PubMed  PubMed Central  Google Scholar 

  4. Yonezawa S, Higashi M, Yamada N, Yokoyama S, Kitamoto S, Kitajima S, Goto M (2011) Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int 61:697–716

    Article  CAS  Google Scholar 

  5. Albrecht H, Carraway KL (2011) 3rd MUC1 and MUC4: switching the emphasis from large to small. Cancer Biother Radiopharm 26:261–271

    Article  CAS  Google Scholar 

  6. Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9:874–885

    Article  CAS  Google Scholar 

  7. Kim SM, Oh SJ, Hur B (2012) Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. Korean J Pathol 46:429–435

    Article  Google Scholar 

  8. Vandenhaute B, Buisine MP, Debailleul V, Clément B, Moniaux N, Dieu MC, Degand P, Porchet N, Aubert JP (1997) Mucin gene expression in biliary epithelial cells. J Hepatol 27:1057–1066

    Article  CAS  Google Scholar 

  9. Kumari S, Puneet PSB, Yadav SS, Kumar M, Khanna A et al (2016) Cyclin D1 andcyclin E2 are differentially expressed in gastric cancer. Med Oncol 33:40

    Article  Google Scholar 

  10. Shukla HS, Tewari M (2007) Laparoscopy and gallbladder cancer. J Surg Oncol 96:91–92

    Article  CAS  Google Scholar 

  11. Henson DE, Albores-Saavedra J, Corle D (1992) Carcinoma of the gallbladder. histologic types, stage of disease, grade, and survival rates. Cancer 70:1493–1497

    Article  CAS  Google Scholar 

  12. Shukla VK, Pandey S, Pandey LK, Roy SK, Vaidya MP (1985) Primary hepatic pregnancy. Postgrad Med J 61:831–832

    Article  CAS  Google Scholar 

  13. Ringel J, Löhr M (2003) The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer 2:9

    Article  Google Scholar 

  14. Gautam SK, Kumar S, Dam V, Ghersi D, Jain M, Batra SK (2020) MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Semin Immunol 47:101391

    Article  CAS  Google Scholar 

  15. Bhoge A, Khandeparkar SGS, Joshi AR, Gogate B, Kulkarni MM, Bhayekar P (2017) Immunohistochemical study of MUC1 and MUC5AC expression in gall bladder lesions. J Clin Diagn Res 11(7):EC12–EC16

    PubMed  PubMed Central  Google Scholar 

  16. Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS (2009) Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 22:649–657

    Article  CAS  Google Scholar 

  17. Barreto SG, Haga H, Shukla PJ (2009) Hormones and gallbladder cancer in women. Indian J Gastroenterol 28:126–130

    Article  Google Scholar 

  18. Levin B (1999) Gallbladder carcinoma. Ann Oncol 4:129–130

    Article  Google Scholar 

  19. Nervi F, Duarte I, Gomez G et al (1988) Frequency of gallbladder cancer in Chile. Int J Cancer 41:657–660

    Article  CAS  Google Scholar 

  20. Diehl AK (1983) Gallstone size and the risk of gallbladder cancer. JAMA 250:2323–2326

    Article  CAS  Google Scholar 

  21. Nakamura S, Sakaguchi S, Suzuki S, Muro H (1989) Aggressive surgery for carcinoma of gallbladder. Surgery 106:467–472

    CAS  PubMed  Google Scholar 

  22. Xiong L, Yang Z, Yang L, Liu J (2012) Miao X (2012) Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. J Surg Oncol 105(1):97–103

    Article  CAS  Google Scholar 

  23. Kaufman M, Mehrotra B, Limaye S, White S, Fuchs A, Lebowicz Y, Nissel-Horowitz S, Thomas A (2008) EGFR expression in gallbladder carcinoma in North America. Int J Med Sci 5:285–291

    Article  CAS  Google Scholar 

  24. Lee HK, Cho MS, Kim TH (2012) Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol 10:224

    Article  Google Scholar 

  25. Yamato T, Sasaki M, Watanabe Y, Nakanuma Y (1999) Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gallbladder carcinoma: an immunohistochemical and in situ hybridization study. J Pathol 188:30–37

    Article  CAS  Google Scholar 

  26. Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK (2001) Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 7:4033–4040

    CAS  PubMed  Google Scholar 

  27. Sasaki M, Nakanuma Y, Kim YS (1996) Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 24:1074–1078

    Article  CAS  Google Scholar 

  28. Boonla C, Wongkham S, Sheehan JK, Wongkham C, Bhudhisawasdi V, Tepsiri N, Pairojkul C (2003) Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 98:1438–1443

    Article  CAS  Google Scholar 

  29. Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS (1999) Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Int 49:38–44

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varansi, 221005, India

    Puneet Kumar, Priyesh Shukla, Soni Kumari, Ruhi Dixit & A. K. Khanna

  2. Cancer Genetics Laboratory, Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India

    Gopeshwar Narayan

  3. Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varansi, 221005, India

    V. K. Dixit

Authors
  1. Puneet Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priyesh Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soni Kumari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruhi Dixit
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gopeshwar Narayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. K. Dixit
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. K. Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PK, PS, GN, VKD, AKK-Conceptualization.

PK, PS, SK, GN- Study design.

PS, SK-Project writing and management.

PK, PS, GN-Defining the study.

PS-Extensive literature work.

Experiments performing.

PS, SK-Practical work.

PS, SK-Operative work.

PS, SK-Data acquisition.

PK, PS, SK, GN-Data analysis.

PK, PS, SK, GN-Statistical inferences.

PK, PS, SK, RD, GN-Manuscript writing and editing.

PK, GN, VKD, AKK-Reviewing of the manuscript.

Corresponding author

Correspondence to Puneet Kumar.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, P., Shukla, P., Kumari, S. et al. Expression of Mucoproteins in Gallbladder Cancer . Indian J Surg 84, 456–462 (2022). https://doi.org/10.1007/s12262-021-02989-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-021-02989-7

Keywords

Search

Navigation